TTX-CINP-201

Purpose

A multicentre, randomized, double-blind, placebo-controlled Phase II clinical study of TTX in the treatment of moderate to severe neuropathic pain caused by chemotherapy in patients with cancer.

The study aims to determine the safety and effectiveness of TTX in patients with neuropathic pain caused by chemotherapy. In addition, the time to the start and the duration of the pain relief, whether TTX helps in reducing the use of other painkillers, and whether TTX helps in reducing symptoms other than pain will also be studied.
Learn More: